The Interprofessional Medication Assessment for Older Patients

June 10, 2016 updated by: East Savo Hospital District

The Interprofessional Medication Assessment for Older Patients - a Multicenter Randomized Trial in Primary Care Setting

The objective of this pragmatic multi-center randomized controlled trial is to test the effectiveness of interprofessional medication assessment in older patients needing home care due to their diseases or decreased functional capacity in primary care. The main hypothesis is that intervention has a positive impact on functional capacity and for rational and safe use of medicines.

Study Overview

Detailed Description

Aging increases the risk of adverse effects and interactions caused by medication. Medication reconciliation and medication review are well-known practices to optimize medicines use. Both interventions usually require a team-based approach to be effective. Medication reconciliation is the process of obtaining and documenting a complete and accurate list of current patient medications and comparing this list with medication orders at each point of care transition to identify and rectify any discrepancies before patient harm occurs. Medication review is the process of evaluating current medication treatment to manage the risk and optimize the outcomes of medication treatment by detecting, solving, and preventing medication-related problems. The present study focuses on medication assessment including both medication reconciliation and review combined to clinical assessment of an individual patient.

According to a systematic review there is a need for research focusing on medication management in community settings and especially to assess the impact of medication assessment on clinical outcomes.

Study Type

Interventional

Enrollment (Actual)

514

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Forssa, Finland, FI 30100
        • Welfare district of Forssa
      • Haapajärvi, Finland, FI 85800
        • Selänne Basic Health Care District
      • Juva, Finland, FI-51900
        • Juva Health Care
      • Lahti, Finland, FI-15100
        • City of Lahti, home care
      • Savonlinna, Finland, FI-57100
        • Eastern Savo Hospital District

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Home dwelling ≥65 years-old persons registered to public home care services and who

  1. have had dizziness, orthostatic hypotension or have fallen or
  2. use at least six medicines

Exclusion Criteria:

Home care is not responsible for patient's medication, for example due to severe chronic illness (for example severe renal insufficiency or cancer with active treatment in secondary or tertiary care).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Active comparator
In addition to usual care, participants allocated to intervention group will receive medication assessment and treatment plan based on it

Intervention

  • Phase I: A medication assessment conducted by an interprofessional team including nurse, pharmacist and physician. The assessment is based on current medication list and basic information cathered by nurse.
  • Phase II: This phase is needed if the assessment cannot be conducted safely without physical examination conducted by physician. The comprehensive interprofessional assessment takes place after the clinical examination conducted by home care physician.
No Intervention: Usual care
Usual care (reference group).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Functional capacity IADL (Instrumental Activities of Daily Living)
Time Frame: at 6 months from baseline
at 6 months from baseline
Functional capacity ADL (Activities of daily living;KATZ)
Time Frame: at 6 months from baseline
at 6 months from baseline
Functional capacity TUG (Timed up and go)
Time Frame: at 6 months from baseline
at 6 months from baseline
Functional capacity MMSE ( Mini-mental state examination)
Time Frame: at 6 months from baseline
at 6 months from baseline
Functional capacity GDS (Geriatric Depression Scale)-15
Time Frame: at 6 months from baseline
at 6 months from baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Use of health care services
Time Frame: at 6 and 12 months from baseline
visits to physician, hospital days and nursing care at home
at 6 and 12 months from baseline
Need of services delivered to home
Time Frame: at 6 and 12 months from baseline
at 6 and 12 months from baseline
Number of medicines
Time Frame: at 6 and 12 months from baseline
at 6 and 12 months from baseline
Quality of medicines
Time Frame: at 6 and 12 months from baseline
at 6 and 12 months from baseline
Cost of medicines
Time Frame: at 6 and 12 months from baseline
at 6 and 12 months from baseline
Health related quality of life assessed with EQ-5D
Time Frame: at 6 and 12 months from baseline
at 6 and 12 months from baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Pekka Mäntyselkä, MD, PROFESSOR

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2015

Primary Completion (Actual)

June 1, 2016

Study Completion (Anticipated)

December 1, 2018

Study Registration Dates

First Submitted

March 13, 2015

First Submitted That Met QC Criteria

March 20, 2015

First Posted (Estimate)

March 26, 2015

Study Record Updates

Last Update Posted (Estimate)

June 13, 2016

Last Update Submitted That Met QC Criteria

June 10, 2016

Last Verified

June 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • ILMA

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Multimorbidity

Clinical Trials on Medication assessment and treatment plan based on it

Subscribe